1. 388 Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors. (9th November 2020) Authors: Bendell, Johanna; Messersmith, Wells; Rasco, Drew; Wang-Gillam, Andrea; Park, Wungki; Zhou, Lei; Carter, Laura; Bruey, Jean-Marie; Li, Jack; Ferguson, Beatrice; Dupont, Jakob; Chaney, Marya; Bono, Johann De Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 388 Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors. (9th November 2020) Authors: Bendell, Johanna; Messersmith, Wells; Rasco, Drew; Wang-Gillam, Andrea; Park, Wungki; Zhou, Lei; Carter, Laura; Bruey, Jean-Marie; Li, Jack; Ferguson, Beatrice; Dupont, Jakob; Chaney, Marya; Bono, Johann De Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 389 Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors. (10th December 2020) Authors: Messersmith, Wells; Rasco, Drew; Bono, Johann De; Wang-Gillam, Andrea; Park, Wungki; Nickle, David; Galkin, Anna; Ferguson, Beatrice; Carter, Laura; Zhou, Lei; Dupont, Jakob; Chaney, Marya; Bendell, Johanna; Bruey, Jean-Marie Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 389 Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors. (9th November 2020) Authors: Messersmith, Wells; Rasco, Drew; Bono, Johann De; Wang-Gillam, Andrea; Park, Wungki; Nickle, David; Galkin, Anna; Ferguson, Beatrice; Carter, Laura; Zhou, Lei; Dupont, Jakob; Chaney, Marya; Bendell, Johanna; Bruey, Jean-Marie Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 404 ALX148, a CD47 blocker, in combination with standard chemotherapy and antibody regimens in patients with gastric/gastroesophageal junction (GC) cancer and head and neck squamous cell carcinoma (HNSCC). (10th December 2020) Authors: Lee, Keun-Wook; Chung, Hyun; Kim, Won Seog; Chow, Laura; Lakhani, Nehal; Messersmith, Wells; Bang, Yung-Jue; LoRusso, Patricia; Fanning, Philip; Squifflet, Pierre; Jin, Feng; Forgie, Alison; Wan, Hong; Pons, Jaume; Randolph, Sophia; Gainor, Justin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Benchmarks for Academic Oncology Faculty. Issue 3 (March 2021) Authors: Anthony, Lowell; Atweh, George; Bhatia, Ravi; Carey, Lisa A.; Chang, Jenny C.; Edelman, Martin J.; Kantoff, Philip W.; Markham, Merry Jennifer; Messersmith, Wells; Nelson, Edward L.; Oettel, Kurt; O'Regan, Ruth; Verschraegen, Claire F.; Vose, Julie M. Journal: JCO oncology practice Issue: Volume 17:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018). Issue 1 (13th February 2019) Authors: Berry, Sneha; Giraldo, Nicolas; Nguyen, Peter; Green, Benjamin; Xu, Haiying; Ogurtsova, Aleksandra; Soni, Abha; Succaria, Farah; Wang, Daphne; Roberts, Charles; Stein, Julie; Engle, Elizabeth; Pardoll, Drew; Anders, Robert; Cottrell, Tricia; Taube, Janis M.; Tran, Ben; Voskoboynik, Mark; Kuo, Jam... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer. Issue 8 (23rd March 2017) Authors: Chapman, Brandon C.; Hosokawa, Patrick; Henderson, William; Paniccia, Alessandro; Overbey, Douglas M.; Messersmith, Wells; Lieu, Christopher; Stiegmann, Greg V.; Schulick, Richard D.; Gajdos, Csaba Journal: Journal of surgical oncology Issue: Volume 115:Issue 8(2017) Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Oxaliplatin-Induced Neuropathy in Colorectal Cancer. (12th December 2011) Authors: Weickhardt, Andrew; Wells, Keith; Messersmith, Wells Other Names: Bonetti Andrea Academic Editor. Journal: Journal of oncology Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer. (19th January 2016) Authors: Leichman, Lawrence; Groshen, Susan; O'Neil, Bert H.; Messersmith, Wells; Berlin, Jordan; Chan, Emily; Leichman, Cynthia G.; Cohen, Steven J.; Cohen, Deirdre; Lenz, Heinz-Josef; Gold, Philip; Boman, Bruce; Fielding, Anitra; Locker, Gershon; Cason, Ronald C.; Hamilton, Stan R.; Hochster, Howard S. Journal: Oncologist Issue: Volume 21:Number 2(2016) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗